Capital World Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4B Buy
15,621,813
+590,063
+4% +$598M 1.96% 8
2025
Q4
$16.2B Buy
15,031,750
+61,851
+0.4% +$59.1M 2.2% 9
2025
Q3
$11.4B Sell
14,969,899
-2,664,593
-15% -$1.98B 1.56% 8
2025
Q2
$13.7B Sell
17,634,492
-748,081
-4% -$581M 2% 7
2025
Q1
$15.2B Sell
18,382,573
-1,169,934
-6% -$973M 2.46% 5
2024
Q4
$15.1B Sell
19,552,507
-803,439
-4% -$665M 2.29% 6
2024
Q3
$18B Sell
20,355,946
-1,457,817
-7% -$1.31B 2.8% 4
2024
Q2
$19.7B Sell
21,813,763
-2,722,292
-11% -$2.18B 3.22% 4
2024
Q1
$19.1B Sell
24,536,055
-2,413,718
-9% -$1.72B 3.16% 3
2023
Q4
$15.7B Buy
26,949,773
+89,720
+0.3% +$52.4M 2.79% 3
2023
Q3
$14.4B Sell
26,860,053
-7,528
-0% -$3.88M 2.86% 4
2023
Q2
$12.6B Sell
26,867,581
-720,959
-3% -$302M 2.42% 4
2023
Q1
$9.47B Sell
27,588,540
-599,899
-2% -$202M 1.96% 6
2022
Q4
$10.3B Sell
28,188,439
-836,435
-3% -$297M 2.2% 6
2022
Q3
$9.39B Buy
29,024,874
+282,228
+1% +$89.4M 2.11% 7
2022
Q2
$9.32B Buy
28,742,646
+6,384,202
+29% +$1.92B 1.98% 7
2022
Q1
$6.4B Buy
22,358,444
+3,242,548
+17% +$834M 1.1% 15
2021
Q4
$5.28B Buy
19,115,896
+2,325,514
+14% +$590M 0.84% 22
2021
Q3
$3.88B Buy
16,790,382
+1,502,363
+10% +$371M 0.66% 31
2021
Q2
$3.51B Buy
15,288,019
+683,842
+5% +$137M 0.6% 33
2021
Q1
$2.73B Buy
14,604,177
+11,750,226
+412% +$2.3B 0.5% 44
2020
Q4
$482M Sell
2,853,951
-224,418
-7% -$33.5M 0.09% 202
2020
Q3
$456M Buy
3,078,369
+445
+0% +$68.9K 0.1% 199
2020
Q2
$505M Buy
3,077,924
+43,075
+1% +$6.61M 0.12% 163
2020
Q1
$421M Buy
3,034,849
+1,706,354
+128% +$234M 0.12% 144
2019
Q4
$175M Sell
1,328,495
-11,769
-0.9% -$1.36M 0.04% 267
2019
Q3
$150M Sell
1,340,264
-129,783
-9% -$14.4M 0.04% 263
2019
Q2
$163M Buy
1,470,047
+58,247
+4% +$6.86M 0.04% 263
2019
Q1
$183M Hold
1,411,800
0.04% 256
2018
Q4
$163M Buy
1,411,800
+398,500
+39% +$44.5M 0.04% 244
2018
Q3
$109M Buy
1,013,300
+648,300
+178% +$64.8M 0.03% 307
2018
Q2
$31.1M Buy
365,000
+150,000
+70% +$12.3M 0.01% 414
2018
Q1
$16.6M Hold
215,000
﹤0.01% 451
2017
Q4
$18.2M Buy
+215,000
New +$18.3M ﹤0.01% 439
2017
Q2
Sell
-1,174,000
Closed -$98.7M 506
2017
Q1
$98.7M Hold
1,174,000
0.02% 292
2016
Q4
$86.3M Sell
1,174,000
-5,200,000
-82% -$387M 0.02% 289
2016
Q3
$512M Buy
6,374,000
+60,000
+1% +$4.8M 0.13% 146
2016
Q2
$497M Buy
6,314,000
+373,000
+6% +$28.1M 0.13% 145
2016
Q1
$428M Sell
5,941,000
-3,671,800
-38% -$278M 0.12% 162
2015
Q4
$810M Sell
9,612,800
-1,346,000
-12% -$112M 0.23% 109
2015
Q3
$917M Buy
10,958,800
+365,697
+3% +$30.9M 0.27% 98
2015
Q2
$884M Sell
10,593,103
-781,897
-7% -$59.6M 0.24% 106
2015
Q1
$826M Buy
11,375,000
+1,000,000
+10% +$71.2M 0.22% 113
2014
Q4
$716M Buy
10,375,000
+1,800,000
+21% +$121M 0.19% 128
2014
Q3
$556M Buy
8,575,000
+2,575,000
+43% +$163M 0.16% 140
2014
Q2
$373M Sell
6,000,000
-200,000
-3% -$11.9M 0.1% 184
2014
Q1
$365M Buy
6,200,000
+2,000,000
+48% +$112M 0.1% 188
2013
Q4
$214M Sell
4,200,000
-1,000,000
-19% -$50.1M 0.06% 230
2013
Q3
$262M Buy
5,200,000
+2,000,000
+63% +$105M 0.08% 211
2013
Q2
$157M Buy
+3,200,000
New +$174M 0.05% 255

Other funds holding LLY

Capital World Investors's LLY Position: Q1 2026 in Review

Capital World Investors increased its Eli Lilly (LLY) stake by 3.9% in Q1 2026, buying an estimated $598M and bringing the position to 15,621,813 shares worth $14.4B. The position accounts for 1.96% of the portfolio, ranked #8.

Capital World Investors first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $19.7B in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capital World Investors held 15,621,813 shares of Eli Lilly worth $14.4B as of Q1 2026.
  • Capital World Investors bought 590,063 Eli Lilly shares in Q1 2026, an estimated $598M.
  • Eli Lilly made up 1.96% of Capital World Investors's portfolio in Q1 2026, its #8 holding.
  • Capital World Investors first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
  • Capital World Investors's Eli Lilly position peaked at $19.7B in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.